Back

The ceramide-based Coronary Event Risk Test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes mellitus as well as in those without diabetes

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Diabetes and the heart Biomarkers ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Arthur Mader

VIVIT Institute, Feldkirch (Austria)

6 More presentations in this session

Presentation thumbnail
Beta-blockers in diabetes with stable coronary heart disease- a cause for concern?
Assistant Professor A. Malik (Manchester, US)
Abstract Slides
Presentation thumbnail
Peripheral neuropathy and diastolic function are associated with adverse cardiovascular outcome in patients with type 1 diabetes mellitus: results from the thousand & 1 study
Doctor M. Jensen (Herlev, DK)
Abstract
Presentation thumbnail
Heterogeneity of treatment effects from an intensive lifestyle weight loss intervention on cardiovascular events in patients with type 2 diabetes: data from the Look AHEAD trial.
Miss T. de Vries (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment
Doctor I. Ikonomidis (Athens, GR)
Abstract
Presentation thumbnail
Tissue sodium concentration emerged as a determinant of hypertrophic vascular remodeling in type 2 diabetes
Miss S. Jung (Erlangen, DE)
Abstract Slides

Access the full session

Session thumbnail
Diabetes and the heart

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources